Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-30
2011-08-30
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S001000, C544S184000
Reexamination Certificate
active
08008315
ABSTRACT:
The present invention is directed to compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.
Nantermet Philippe G.
Rajapakse Hemaka Anthony
Selnick Harold G.
Devlin Gerard M.
MacMillan Keith D.
Merck Sharp & Dohme Corp.
Ward Paul V.
LandOfFree
Benzylether and benzylamino beta-secretase inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzylether and benzylamino beta-secretase inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylether and benzylamino beta-secretase inhibitors for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742457